DSFIR 📈 DSM-Firmenich - Overview
Exchange: AS • Country: Switzerland • Currency: EUR • Type: Common Stock • ISIN: CH1216478797
DSFIR: Perfumes, Flavors, Vitamins, Enzymes, Probiotics, Nutrients, Pharmaceuticals
DSM-Firmenich AG is a global leader in providing innovative solutions for the nutrition, health, and beauty industries, with a presence in key regions including Switzerland, the Netherlands, Europe, the Middle East, Africa, North America, Latin America, China, and the rest of Asia. The company's diversified portfolio is structured around four main segments: Perfumery & Beauty, Taste, Texture & Health, Health, Nutrition & Care, and Animal Nutrition & Health. Each segment is designed to address specific needs within the broader nutrition, health, and beauty markets.
The Perfumery & Beauty segment is focused on the creation of scents using a wide range of ingredients, from natural and synthetic to biotech. This involves the development of fragrances for various applications, including personal care products, fine fragrances, and home care. By leveraging its expertise in fragrance creation, DSM-Firmenich AG is able to provide its customers with unique and captivating scents that enhance the appeal of their products. Meanwhile, the Taste, Texture & Health segment concentrates on delivering solutions for the food and beverage industry, encompassing flavors, natural extracts, and sugar reduction solutions, as well as food enzymes, cultures, hydrocolloids, proteins, natural colorants, nutritional ingredients, premixes, and yeast extracts. This segment plays a crucial role in helping food manufacturers create products that are not only tasty and appealing but also healthier and more sustainable.
The Animal Nutrition & Health segment offers a comprehensive range of solutions for the animal production industry, including animal proteins, vitamins, performance solutions, and data-driven precision services. These solutions are designed to support the health and well-being of animals, while also enhancing the efficiency and sustainability of animal production. By providing high-quality nutritional products and expert services, DSM-Firmenich AG helps its customers in the animal nutrition sector to improve the performance of their operations and contribute to a more sustainable food system. On the other hand, the Health, Nutrition & Care segment is dedicated to serving the early life nutrition, dietary supplement, pharmaceutical, biomedical materials, and nutrition improvement markets. This segment provides an extensive array of products and services, including vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, probiotics, prebiotics, active pharmaceutical ingredients, and biomedical solutions, as well as premix and market-ready solutions, personalized nutrition solutions, regulatory affairs, and formulation expertise services.
With a rich history dating back to 1902, DSM-Firmenich AG has established itself as a trusted and innovative partner for businesses across the nutrition, health, and beauty spectrum. Headquartered in Kaiseraugst, Switzerland, the company is committed to driving growth and sustainability through its operations, while also creating value for its customers, shareholders, and the wider community. As a publicly traded company with a strong presence in the global markets, DSM-Firmenich AG is well-positioned to capitalize on emerging trends and opportunities in the personal care products sector, which is classified under the GICS Sub Industry. For more information about the company's activities, mission, and values, please visit its official website at https://www.dsm-firmenich.com, or refer to its ISIN code: CH1216478797, which is listed as a common stock.
Additional Sources for DSFIR Stock
DSFIR Stock Overview
Market Cap in USD | 29,192m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Personal Care Products |
IPO / Inception |
DSFIR Stock Ratings
Growth 5y | -20.8% |
Fundamental | -41.3% |
Dividend | 54.1% |
Rel. Strength Industry | -21.8 |
Analysts | - |
Fair Price Momentum | 80.51 EUR |
Fair Price DCF | 55.73 EUR |
DSFIR Dividends
Dividend Yield 12m | 2.72% |
Yield on Cost 5y | 2.36% |
Annual Growth 5y | 25.00% |
Payout Consistency | 100.0% |
DSFIR Growth Ratios
Growth Correlation 3m | -91% |
Growth Correlation 12m | 67.1% |
Growth Correlation 5y | 55.2% |
CAGR 5y | -8.08% |
CAGR/Mean DD 5y | -0.52 |
Sharpe Ratio 12m | 0.32 |
Alpha | -6.06 |
Beta | 0.53 |
Volatility | 23.98% |
Current Volume | 850.6k |
Average Volume 20d | 478.1k |
As of December 22, 2024, the stock is trading at EUR 97.88 with a total of 850,590 shares traded.
Over the past week, the price has changed by -4.85%, over one month by -5.54%, over three months by -15.43% and over the past year by +10.60%.
Probably not. Based on ValueRay Fundamental Analyses, DSM-Firmenich (AS:DSFIR) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -41.31 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DSFIR as of December 2024 is 80.51. This means that DSFIR is currently overvalued and has a potential downside of -17.75%.
DSM-Firmenich has no consensus analysts rating.
According to ValueRays Forecast Model, DSFIR DSM-Firmenich will be worth about 87.4 in December 2025. The stock is currently trading at 97.88. This means that the stock has a potential downside of -10.71%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 132.2 | 35.1% |
Analysts Target Price | - | - |
ValueRay Target Price | 87.4 | -10.7% |